Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C01CA06	PHENYLEPHRINE HYDROCHLORIDE	G	Phenylephrine HCl - 10mg/ml	1%	Injectable solution	10,282,281 L.L
G03DA04	PROGESTOGEL	B	Progesterone - 1%	1%	Gel	542,912 L.L
G03DA04	PROGESTOGEL	B	Progesterone - 1%	1%	Gel	542,912 L.L
N04BC05	PRAMIPEXOLE BIOGARAN	G	Pramipexole (dihydrochloride monohydrate) - 0.7mg	0.7mg	Tablet	1,733,557 L.L
R03BA02	PULMICORT	B	Budesonide - 0.5mg/ml	0.5mg/ml	Inhalation suspension for nebuliser	2,015,764 L.L
N05BA12	PAZOLAM	G	Alprazolam - 0.5mg	0.5mg	Tablet	563,070 L.L
L04AA27	PMS-FINGOLIMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	19,351,580 L.L
L04AD02	PROGRAF 0.5 MG	B	Tacrolimus - 0.5mg	0.5mg	Capsule	L.L
G02CB03	PROCTIN	G	Cabergoline - 0.5mg	0.5mg	Tablet	350,679 L.L
G02CB03	PROCTIN	G	Cabergoline - 0.5mg	0.5mg	Tablet	1,300,328 L.L
G02CB03	PROCTINMED	G	Cabergoline - 0.5mg	0.5mg	Tablet	473,545 L.L
G02CB03	PROCTINMED	G	Cabergoline - 0.5mg	0.5mg	Tablet	1,689,402 L.L
L04AD02	PROGRAF 0.5 MG	B	Tacrolimus - 0.5mg	0.5mg	Capsule	13,942,481 L.L
L04AD02	PROGRAF 0.5 MG	B	Tacrolimus - 0.5mg	0.5mg	Capsule	13,942,481 L.L
P01AB01	POLGYL	G	Metronidazole - 0.5%	0.5%	Injectable solution	134,384 L.L
M02AA07	PIROXICALM	G	Piroxicam - 0.5%	0.5%	Gel	207,336 L.L
G04CA02	PROSTAFINE	G	Tamsulosin HCl - 0.4mg	0.4mg	Capsule, modified release	761,511 L.L
D07AC18	PEITEL	B	Prednicarbate - 0.25%	0.25%	Cream	507,972 L.L
N04BC05	PRAMIPEXOLE BIOGARAN	G	Pramipexole (dihydrochloride monohydrate) - 0.18mg	0.18mg	Tablet	440,780 L.L
D07AC14	PRENIDERM	G	Methylprednisolone aceponate - 0.1%	0.1%	Cream	312,283 L.L
D11AH01	PROTOPIC	B	Tacrolimus monohydrate - 0.1%	0.1%	Ointment	2,127,303 L.L
S01GX09	PATANOL	B	Olopatadine (HCl) - 0.1%	0.1%	Drops solution	873,498 L.L
C09BA04	PRETERAX ARGININE	B	Perindopril arginine - 2.5mg, Indapamide - 0.625mg		Tablet, film coated	452,875 L.L
A01AD11	PYRALVEX	B	Salicylic acid - 0.01g/ml, Rhubarb (Anthraquinone Glycosides) - 0.05g/ml		Solution	327,898 L.L
L01XY02	PHESGO	BioTech	Pertuzumab - 600mg, Trastuzumab - 600mg		Injectable solution	326,054,156 L.L
C09BB04	PRESORYL PLUS	G	Perindopril arginine - 5mg, Amlodipine (besylate) - 5mg		Tablet	557,695 L.L
L01XY02	PHESGO	BioTech	Pertuzumab - 1200mg, Trastuzumab - 600mg		Injectable solution	591,417,874 L.L
C09BB04	PRESORYL PLUS	G	Perindopril arginine - 10mg, Amlodipine (besylate) - 5mg		Tablet	770,022 L.L
C09BB04	PRESORYL PLUS	G	Perindopril arginine - 10mg, Amlodipine (besylate) - 10mg		Tablet	770,022 L.L
R06AA52	PULMONAL EXPECTORANT	G	Diphenhydramine HCl - 0.015g/5ml, Ammonium HCl - 0.1g/5ml		Syrup	177,899 L.L

...